{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:31:35Z","timestamp":1790951495652,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.rpth.2024.102385","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T16:31:24Z","timestamp":1710779484000},"page":"102385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Testing for the lupus anticoagulant: the good, the bad, and the ugly"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2103-1661","authenticated-orcid":false,"given":"Emmanuel J.","family":"Favaloro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8237-6743","authenticated-orcid":false,"given":"Leonardo","family":"Pasalic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3051-4427","authenticated-orcid":false,"given":"Rita","family":"Selby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2024.102385_bib1","article-title":"Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management","volume":"380","author":"Knight","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2024.102385_bib2","first-page":"1687","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"75","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rpth.2024.102385_bib3","first-page":"2164","article-title":"Laboratory diagnosis of antiphospholipid syndrome: insights and hindrances","volume":"11","author":"Vandevelde","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.rpth.2024.102385_bib4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/jth.13976","article-title":"Subcommittee on lupus anticoagulant\/antiphospholipid antibodies. Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH","volume":"16","author":"Devreese","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102385_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-1-0716-3175-1_15","article-title":"An overview of laboratory testing for antiphospholipid antibodies","volume":"2663","author":"Favaloro","year":"2023","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.rpth.2024.102385_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-4939-7196-1_16","article-title":"Solid phase immunoassay for the detection of anticardiolipin antibodies","volume":"1646","author":"Willis","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.rpth.2024.102385_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-4939-7196-1_17","article-title":"Solid phase immunoassay for the detection of anti-\u03b2(2) glycoprotein I antibodies","volume":"1646","author":"Willis","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.rpth.2024.102385_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-1-0716-3175-1_19","article-title":"Antiphospholipid antibody testing for anti-cardiolipin and anti-\u03b22 glycoprotein I antibodies using chemiluminescence-based panels","volume":"2663","author":"Favaloro","year":"2023","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.rpth.2024.102385_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12676","article-title":"Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants","volume":"6","author":"Favaloro","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102385_bib10","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-0716-3175-1","article-title":"Variable performance of lupus anticoagulant testing: the Australasian experience","author":"Favaloro","year":"2023","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2024.102385_bib11","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation","volume":"18","author":"Devreese","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102385_bib12","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/jth.14846","article-title":"Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis","volume":"18","author":"Tripodi","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102385_bib13","series-title":"Laboratory testing for the lupus anticoagulant; approved guideline. CLSI document H60-A","year":"2014"},{"key":"10.1016\/j.rpth.2024.102385_bib14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/bjh.16308","article-title":"Addendum to British Society for Haematology Guidelines on investigation and management of antiphospholipid syndrome, 2012 (Br. J. Haematol. 2012; 157: 47-58): use of direct acting oral anticoagulants","volume":"189","author":"Arachchillage","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102385_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2141.2012.09037.x","article-title":"British Committee for Standards in Haematology. Guidelines on the investigation and management of antiphospholipid syndrome","volume":"157","author":"Keeling","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102385_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-4939-7196-1_15","article-title":"Lupus anticoagulant testing: activated partial thromboplastin time (APTT) and silica clotting time (SCT)","volume":"1646","author":"Tripodi","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.rpth.2024.102385_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-1-4939-7196-1_14","article-title":"Lupus anticoagulant testing: diluted Russell Viper venom time (dRVVT)","volume":"1646","author":"Pengo","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.rpth.2024.102385_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-0716-3175-1_17","article-title":"Lupus anticoagulant testing: dilute prothrombin time (dPT)","volume":"2663","author":"Moore","year":"2023","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.rpth.2024.102385_bib19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-1-0716-3175-1_16","article-title":"Lupus anticoagulant testing: Taipan snake venom time with Ecarin time as confirmatory test","volume":"2663","author":"Moore","year":"2023","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.rpth.2024.102385_bib20","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1111\/jth.15438","volume":"19","author":"Moore","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102385_bib21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0035-1546827","article-title":"Laboratory testing in the era of direct or non-vitamin k antagonist oral anticoagulants: a practical guide to measuring their activity and avoiding diagnostic errors","volume":"41","author":"Favaloro","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2024.102385_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ajh.25669","article-title":"Coagulation mixing studies: utility, algorithmic strategies and limitations for lupus anticoagulant testing or follow up of abnormal coagulation tests","volume":"95","author":"Favaloro","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2024.102385_bib23","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis","volume":"7","author":"Pengo","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2024.102385_bib24","article-title":"Evaluation of the significance of mixing study in lupus anticoagulant testing using a new CMC algorithm [abstract]","volume":"7","author":"Baby","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102385_bib25","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.pathol.2018.11.008","article-title":"Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives","volume":"51","author":"Favaloro","year":"2019","journal-title":"Pathology"},{"key":"10.1016\/j.rpth.2024.102385_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/PAT.0000000000000252","article-title":"The effect of dabigatran on haemostasis tests: a comprehensive assessment using in-vitro and ex-vivo samples","volume":"47","author":"Bonar","year":"2015","journal-title":"Pathology"},{"key":"10.1016\/j.rpth.2024.102385_bib27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pathol.2015.11.025","article-title":"The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in\u00a0vitro and ex\u00a0vivo samples","volume":"48","author":"Bonar","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/j.rpth.2024.102385_bib28","first-page":"1042","article-title":"Simplified method for removing DOAC interference in mechanical coagulation test systems \u2013 a proof of concept","volume":"13","author":"Exner","year":"2024","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.rpth.2024.102385_bib29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1160\/TH12-12-0898","article-title":"Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide","volume":"110","author":"Douxfils","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102385_bib30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1055\/s-0032-1315961","article-title":"Quality standards for sample collection in coagulation testing","volume":"38","author":"Lippi","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2024.102385_bib31","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/s-0032-1319768","article-title":"Quality standards for sample processing, transportation, and storage in hemostasis testing","volume":"38","author":"Adcock Funk","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2024.102385_bib32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.thromres.2019.05.013","article-title":"Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): a comparative study using DOAC Stop and andexanet\u00a0alfa","volume":"180","author":"Favaloro","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2024.102385_bib33","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/jth.15785","article-title":"Added value of antiphosphatidylserine\/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies","volume":"20","author":"Vandevelde","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102385_bib34","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/jth.15287","article-title":"Recommendations for the measurement of thrombin generation: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies","volume":"19","author":"Ninivaggi","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102385_bib35","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1111\/jth.14935","article-title":"Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis","volume":"18","author":"Zuily","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102385_bib36","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1055\/s-0038-1649901","article-title":"Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH","volume":"74","author":"Brandt","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102385_bib37","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1055\/s-0038-1648143","article-title":"Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants","volume":"65","author":"Exner","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102385_bib38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-0038-1667342","article-title":"How to generate a more accurate laboratory-based international normalized ratio: solutions to obtaining or verifying the mean normal prothrombin time and international sensitivity index","volume":"45","author":"Favaloro","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2024.102385_bib39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0038-1677018","article-title":"How to optimize activated partial thromboplastin time (aptt) testing: solutions to establishing and verifying normal reference intervals and assessing aptt reagents for sensitivity to heparin, lupus anticoagulant, and clotting factors","volume":"45","author":"Favaloro","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2024.102385_bib73","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12959-023-00501-7","article-title":"The methods for removal of direct oral anticoagulants and heparins to improve the monitoring of hemostasis: a narrative literature review","volume":"21","author":"Frackiewicz","year":"2023","journal-title":"Thromb J"},{"key":"10.1016\/j.rpth.2024.102385_bib41","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/ijlh.13101","article-title":"Lupus anticoagulant diagnosis in patients receiving direct oral FXa inhibitors at trough levels: a real-life study","volume":"41","author":"Gay","year":"2019","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.rpth.2024.102385_bib42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1160\/TH16-02-0081","article-title":"Lupus-anticoagulant testing at NOAC trough levels","volume":"116","author":"Ratzinger","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102385_bib43","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MBC.0000000000000235","article-title":"False-positive lupus anticoagulant in patients receiving rivaroxaban: 24 h since the last dose are needed to exclude antiphospholipid syndrome","volume":"26","author":"G\u00f3ralczyk","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.rpth.2024.102385_bib44","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1055\/s-0032-1311993","article-title":"Internal quality control and external quality assurance in testing for antiphospholipid antibodies: part II--Lupus anticoagulant","volume":"38","author":"Favaloro","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2024.102385_bib45","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/j.1538-7836.2010.04090.x","article-title":"Laboratory investigation of lupus anticoagulants: mixing studies are sometimes required","volume":"8","author":"Favaloro","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102385_bib46","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/MBC.0b013e328360c71b","article-title":"Lupus anticoagulant testing--sometimes mixing is required: potential for false negatives without mixing studies","volume":"24","author":"Favaloro","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.rpth.2024.102385_bib47","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/PAT.0b013e32834d7b83","article-title":"Evaluating laboratory approaches to the identification of lupus anticoagulants: a diagnostic challenge from the RCPA Haematology QAP","volume":"44","author":"Bonar","year":"2012","journal-title":"Pathology"},{"key":"10.1016\/j.rpth.2024.102385_bib48","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1309\/AJCP4SPPLG5XVIXF","article-title":"Lupus anticoagulant testing: performance and practices by North American clinical laboratories","volume":"134","author":"Dembitzer","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.rpth.2024.102385_bib49","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/jcp.2009.066449","article-title":"Lupus anticoagulant: case-based external quality assessment","volume":"62","author":"van den Besselaar","year":"2009","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.rpth.2024.102385_bib50","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/j.1538-7836.2004.01028.x","article-title":"UK National External Quality Assessment Scheme for Blood Coagulation. Lupus anticoagulant testing using plasma spiked with monoclonal antibodies: performance in the UK NEQAS proficiency testing programme","volume":"2","author":"Jennings","year":"2004","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102385_bib51","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2141.2002.03821.x","article-title":"Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods","volume":"119","author":"Jennings","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102385_bib52","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1055\/s-0037-1614601","article-title":"Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I","volume":"81","author":"Arnout","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102385_bib53","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/ijlh.13818","article-title":"A\u00a0multi-laboratory assessment of lupus anticoagulant assays performed on the ACL TOP 50 family for harmonized testing in a large laboratory network","volume":"44","author":"Favaloro","year":"2022","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.rpth.2024.102385_bib54","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/jth.14596","article-title":"Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository","volume":"17","author":"Efthymiou","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102385_bib55","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fimmu.2019.00376","article-title":"Reliability of lupus anticoagulant and anti-phosphatidylserine\/prothrombin autoantibodies in antiphospholipid syndrome: a multicenter study","volume":"10","author":"Sciascia","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.rpth.2024.102385_bib56","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/MBC.0000000000000414","article-title":"Lupus anticoagulant: a multicenter study for a standardized and harmonized reporting","volume":"27","author":"Poz","year":"2016","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.rpth.2024.102385_bib57","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/jalm\/jfab134","article-title":"Antiphospholipid antibodies and the antiphospholipid syndrome: from coagulation to the clinic","volume":"7","author":"Selby","year":"2022","journal-title":"J\u00a0Appl Lab Med"},{"key":"10.1016\/j.rpth.2024.102385_bib58","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome","volume":"132","author":"Pengo","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102385_bib59","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/jth.15158","article-title":"Trial of rivaroxaban in antiphospholipid syndrome (TRAPS): two-year outcomes after the study closure","volume":"19","author":"Pengo","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102385_bib60","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/M19-0291","article-title":"Rivaroxaban versus vitamin k antagonist in antiphospholipid syndrome: a randomized noninferiority trial","volume":"171","author":"Ordi-Ros","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rpth.2024.102385_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2023.100147","article-title":"Associations among antiphospholipid antibody types, isotypes, and titers: an AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study","volume":"103","author":"Gkrouzman","year":"2023","journal-title":"Lab Invest"},{"key":"10.1016\/j.rpth.2024.102385_bib62","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1177\/09612033221128742","article-title":"Immunosuppression use in primary antiphospholipid antibody-positive patients: descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository (\"Registry\")","volume":"31","author":"Erton","year":"2022","journal-title":"Lupus"},{"key":"10.1016\/j.rpth.2024.102385_bib63","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000633","article-title":"Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository ('Registry')","volume":"9","author":"Erton","year":"2022","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.rpth.2024.102385_bib64","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/acr.24468","article-title":"Characteristics of patients with antiphospholipid antibody positivity in the APS ACTION International Clinical Database and Repository","volume":"74","author":"Sevim","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.rpth.2024.102385_bib65","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1177\/09612033211062523","article-title":"COVID-19 and antiphospholipid antibodies: a position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)","volume":"30","author":"Wang","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.rpth.2024.102385_bib66","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s42358-021-00222-3","article-title":"Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository","volume":"61","author":"de Azevedo Lopes","year":"2021","journal-title":"Adv Rheumatol"},{"key":"10.1016\/j.rpth.2024.102385_bib67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11926-021-01008-8","article-title":"Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-year update","volume":"23","author":"Erkan","year":"2021","journal-title":"Curr Rheumatol Rep"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2024.102385_bib40","article-title":"Evaluation of charcoal based direct oral anticoagulant (DOAC) neutralisation in the laboratory measurement of lupus anticoagulant (LA) [abstract]","volume":"7","author":"Medforth","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2024.102385_bib68","article-title":"The effect of DOAC-Stop on lupus anticoagulant testing in plasma patients receiving direct oral anticoagulant [abstract]","volume":"7","author":"Klepczyk","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2024.102385_bib69","article-title":"Effect of high-dose direct anticoagulant drugs and DOAC-remove on lupus anticoagulant detection by a hexagonal phase phospholipid assay","volume":"7","author":"Rahman","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2024.102385_bib70","article-title":"Applications of DOAC removal in the laboratory","volume":"7","author":"Jamati","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2024.102385_bib71","article-title":"Performance of different pairs of APTTs with high and low sensitivity to phospholipids to diagnose lupus anticoagulant","volume":"7","author":"Bertoncin","year":"2023","journal-title":"Res Pract Thromb Haemost"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924000748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924000748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T11:08:29Z","timestamp":1717412909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037924000748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2475037924000748"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102385","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testing for the lupus anticoagulant: the good, the bad, and the ugly","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102385"}}